CVMP opinions on veterinary medicinal products

The Committee adopted by consensus a positive opinion for a marketing authorisation from Zoetis Belgium for Lenivia (izenivetmab), for the reduction of pain associated with osteoarthritis in dogs.

The Committee adopted a positive opinion by consensus, recommending the granting of a marketing authorisation for Vaxxitek HVT+IBD+H5 (Avian influenza vaccine (live recombinant)), intended for:

• active immunisation of one-day-old chicks or 18-day-old embryonated chicken eggs to reduce mortality, clinical signs and virus excretion due to infection with highly pathogenic avian influenza virus (HPAI) virus of the H5 subtype, including the circulating clade 2.3.4.4b.
• active immunisation of one-day-old turkeys to reduce mortality, clinical signs and virus excretion due to infection with HPAI virus of the H5 subtype, including the circulating clade 2.3.4.4b.

The applicant for this veterinary product is Boehringer Ingelheim Vetmedica GmbH….